RIDAURA
Identification of Ridaura
| No description |
Google image searchProduct monograph
Active ingredient
auranofin, 3 MG
DIN: 01916823
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: XEDITON PHARMACEUTICALS INC
Date: 17-JUN-2010
ATC:
- M01 — ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS (ATC, ATC/DDD, )
- M01C — SPECIFIC ANTIRHEUMATIC AGENTS (ATC, ATC/DDD)
- M01CB — Gold preparations (ATC, ATC/DDD)
- M01CB03 — AURANOFIN (ATC/DDD)
Reference brand drug: Ridaura
Pharmaceutical standard: MFR
